文献速递瓣膜外科

快速释放生物瓣主动脉瓣置换术后传导障碍

Conduction disturbances following surgical aortic valve replacement with a rapid-deployment bioprosthesis.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-02-19

该单中心真实世界研究纳入700例连续接受快速释放球囊扩张生物瓣行外科主动脉瓣置换术的患者,其中663例纳入分析。术后14天内新发永久起搏器植入累积发生率为9.4%,主要指征为完全性房室传导阻滞(77%)。术前传导异常和合并手术是新发起搏器植入的独立预测因素,起搏器植入对短期至中期生存无显著影响。

要点

  • 快速释放瓣膜术后新发永久起搏器植入率9.4%,主要因完全性房室传导阻滞。
  • 术前传导异常(如右束支传导阻滞)和合并手术是起搏器植入的独立预测因素。
  • 起搏器植入未显著影响短期至中期生存。

核心结论

  • 快速释放瓣膜术后起搏器植入率与既往报道范围一致,且未显著影响短期至中期生存。

主要发现

  • 术后14天内新发永久起搏器植入61例,累积发生率9.4%。
  • 起搏器植入指征为完全性房室传导阻滞47例(77%)。
  • 术前传导异常和合并手术是新发起搏器植入的独立预测因素。

关键数值与推荐

  • 术前传导异常如右束支传导阻滞和合并手术为独立预测因素。
  • 排除基线传导障碍患者可能降低术后起搏器植入率。

临床怎么用

  • 术前评估传导异常,对高风险患者加强心电监测。
  • 考虑排除基线传导障碍患者以降低起搏器植入率。
  • 起搏器植入不显著影响短期至中期生存,但需关注传导障碍。

局限性

  • 单中心真实世界研究,结果外推需谨慎。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The implantation of rapid-deployment aortic valves may interfere with the conduction system of the heart. This study evaluates the occurrence and predictive factors of conduction anomalies in patients undergoing surgical aortic valve replacement (SAVR) with a rapid-deployment balloon-expandable bioprosthesis in a single-center, real-world experience. METHODS: Between May 2010 and April 2019, 700 consecutive patients were included in a prospective, ongoing database with a longitudinal follow-up preoperatively, at discharge, and at 3 months, 1 year, 3 years, and 5 years postoperatively. Thirty-seven patients (5.3%) had a permanent pacemaker at baseline and were excluded from further analysis, leaving 663 patients for analysis. Assessment of conduction anomalies was performed by electrocardiography (ECG) monitoring and repeated 12-lead ECG during the hospital stay and at postoperative follow-ups. RESULTS: Preoperatively, 126 patients (19.0%) presented with different conduction disturbances. New permanent pacemaker implantation (PPI) occurred in 61 patients during the first 14 days (cumulative incidence, 9.4%). The indication for PPI was complete atrioventricular block in 47 cases (77%). Preoperative conduction anomalies, such as right bundle branch block, as well as operative characteristics (concomitant procedures) were found to be independent predictors for new PPI. One-year survival was 98% in patients with new early PPI and 96% in those without new early PPI (P = .60). CONCLUSIONS: The PPI rate was in the range of previous reports for rapid-deployment prostheses. PPI did not have a significant influence on short- to intermediate-term survival. Case selection with exclusion of patients presenting with baseline conduction disturbances may decrease the rate of new PPIs after SAVR with rapid-deployment balloon-expandable bioprostheses.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Coti I, Schukro C, Drevinja F, et al. Conduction disturbances following surgical aortic valve replacement with a rapid-deployment bioprosthesis. J Thorac Cardiovasc Surg. 2020. PMID: 32204909. doi:10.1016/j.jtcvs.2020.01.083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。